We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Clinical Note |

Cutaneous Colocalized Invasive Poorly Differentiated Carcinoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma of the Head and Neck Region:  A Case Report and Review of the Literature

Yan Peng, MD, PhD; Huan-You Wang, MD, PhD; Kyle H. Molberg, MD
Arch Otolaryngol Head Neck Surg. 2009;135(6):606-610. doi:10.1001/archoto.2009.51.
Text Size: A A A
Published online


Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is the most common form of chronic leukemia in the United States and Europe.1 It has been associated with an increased incidence of a second neoplasia, including carcinomas in various parts of the body. For example, in large population-based studies2,3 of solid tumors in patients with CLL/SLL, markedly increased risks were observed for Kaposi sarcoma, malignant melanoma, and carcinomas of the larynx and the lung. In contrast, occurrence of either synchronous (coexisting) or dyssynchronous (subsequent) poorly differentiated carcinoma and CLL/SLL in the skin is extremely rare. There are, so far, only limited single case reports in the literature.4 The case reported herein is another rare example of a cutaneous colocalized invasive poorly differentiated carcinoma and CLL/SLL of the head and neck region.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption
Figure 1.

Morphologic features of the cutaneous colocalized tumors. A, The infiltrate was located in the dermis without any epidermal involvement. It was composed of 2 components: an epithelial element in the lower left region and a lymphoid element in the upper right region (hematoxylin-eosin, original magnification ×20). B, The epithelial component was composed of markedly atypical large cells with irregular nuclear contours and prominent nucleoli (hematoxylin-eosin, original magnification ×1000). C, The lymphoid component formed discrete nodules composed of small mature lymphocytes (hematoxylin-eosin, original magnification ×100). D, At a higher magnification, the small mature lymphoid cells shown in panel C exhibit round nuclear contours, dense chromatin, absent to small nucleoli with scattered larger lymphoid cells with slight open chromatin, and prominent nucleoli, representing prolymphocytes (arrow) (hematoxylin-eosin, original magnification ×1000.)

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Immunohistochemical features of the cutaneous colocalized tumors. The epithelial infiltrate was strongly and diffusely positive for cytokeratin AE1/AE3 (A) and p63 (B). The CD20+ B lymphoid infiltrate (C) coexpressed CD5 (D) compared with scattered CD3+ T lymphocytes (E). (Immunohistochemical staining; original magnification × 100).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

Flow cytometric analysis of the skin biopsy specimen. A minute population of B-lineage cells (red) in the lymphoid gate (A) were positive for CD19 (B and C), CD23 (D), dim positive for CD20 (E), and κ light chain–restricted (F). Interestingly, compared with normal mature T lymphocytes (green), the κ-restricted B-lineage cells were also positive for CD5 (usually considered as a pan–T-lymphocyte marker) (B) but negative for CD10 (C), FMC-7 (D), and predominantly negative for CD38 (E).

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections